A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
New Brunswick, NJ · +19 more sites
7 recruiting lung cancer studies with a site in New Brunswick, NJ.
Sponsor: AstraZeneca
New Brunswick, NJ · +19 more sites
Sponsor: Astellas Pharma Global Development, Inc.
Hackensack, NJ · New Brunswick, NJ · +16 more sites
Sponsor: Summit Therapeutics
Mullica Hill, NJ · New Brunswick, NJ · +95 more sites
Sponsor: SystImmune Inc.
East Brunswick, NJ · Hackensack, NJ · New Brunswick, NJ · +21 more sites
Sponsor: Bristol-Myers Squibb
New Brunswick, NJ · +24 more sites
Sponsor: Xencor, Inc.
New Brunswick, NJ · +19 more sites
Sponsor: Rutgers, The State University of New Jersey
New Brunswick, NJ
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.